Use of fusion protein constructs to generate potent immunotherapy and protection against scorpion toxins

Author： Legros C. Kaabi H. El Ayeb M. Ceard B. Vacher H. Bougis P.E. Martin-Eauclaire M.-F.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.5, 2001-12, pp. : 934-942

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of synthetic peptides can be a misleading approach to generate vaccines against scorpion toxins

By Calderon-Aranda E.S. Olamendi-Portugal T. Possani L.D.

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1198-1206

Elsevier

Access to resources Recommend Favorite

Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus

By Romero C.H. Barrett T. Kitching R.P. Bostock C. Black D.N.

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 36-40

Elsevier

Access to resources Recommend Favorite

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

By Heath D.G. Anderson G.W. Mauro J.M. Welkos S.L. Andrews G.P. Adamovicz J. Friedlander A.M.

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1131-1137

Elsevier

Access to resources Recommend Favorite

In vivo protection against Androctonus australis hector scorpion toxin and venom by immunization with a synthetic analog of toxin II

By Zenouaki I. Kharrat R. Sabatier J.-M. Devaux C. Karoui H. Van Rietschoten J. El Ayeb M. Rochat H.

Vaccine, Vol. 15, Iss. 2, 1997-02 ,pp. : 187-194

Elsevier

Access to resources Recommend Favorite

Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case

By Saikh K.U. Sesno J. Brandler P. Ulrich R.G.

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 1029-1038

Elsevier

Access to resources Recommend Favorite